Molecule News and Research

RSS

Astrazeneca Licenses 3 X-Chem Drug Discovery Programs

...

24 Sep 2013

First Direct Measurement Of Spinal Cord Myelin In MS

...

24 Sep 2013

Abbvie, Galapagos Ink Up To $405M CF Collaboration

...

24 Sep 2013

Astrazeneca Licenses 3 X-Chem Drug Discovery Programs

...

24 Sep 2013

Abbvie, Galapagos Ink Up To $405M CF Collaboration

...

24 Sep 2013

Understanding genetic, physiological basis for metabolic diseases related to circadian function

A new study by a team of University of Notre Dame researchers, which appears in the Sept. 2 edition of the journal PLoS ONE, is a significant step in understanding the molecular genetic and physiological basis for a spectrum of metabolic diseases related to circadian function.

24 Sep 2013

Researchers develop first imaging tool to examine myelin damage in MS

Researchers have made an exciting breakthrough - developing a first-of-its-kind imaging tool to examine myelin damage in multiple sclerosis (MS). An extremely difficult disease to diagnose, the tool will help physicians diagnose patients earlier, monitor the disease's progression, and evaluate therapy efficacy.

24 Sep 2013

Researchers discover drug that halts growth of brain tumor cells

Working with mice, Johns Hopkins researchers have discovered that weeks of treatment with a repurposed FDA-approved drug halted the growth of - and ultimately left no detectable trace of - brain tumor cells taken from adult human patients.

24 Sep 2013

Lpath receives NIH SBIR grant to investigate effect of Lpathomab compound on diabetic neuropathy

Lpath, Inc., the industry leader in lipidomics-based therapeutics, announced receipt of a Notice of Grant Award from the National Institutes of Health (NIH). This $145,000 Phase 1 SBIR grant will support the study of Lpath's therapeutic monoclonal antibody, Lpathomab™, in animal models of diabetic neuropathic pain and diabetic neuropathy.

23 Sep 2013

Researchers report encouraging results from T1DAL study on type 1 diabetes

Encouraging results from the T1DAL study (Targeting effector memory T cells with alefacept in new onset type 1 diabetes), led by Mark R. Rigby MD, PhD from Indiana University and Riley Hospital for Children in Indianapolis and sponsored by the Immune Tolerance Network (ITN) with additional support from JDRF, are published today in The Lancet Diabetes & Endocrinology.

23 Sep 2013

New study on propofol drug may help develop effective anesthetics with fewer side effects

Researchers at Washington University School of Medicine in St. Louis and Imperial College London have identified the site where the widely used anesthetic drug propofol binds to receptors in the brain to sedate patients during surgery.

23 Sep 2013

Sodium-potassium pump is pivotal to body's function

The story of the sodium-potassium pump has strong ties to Denmark. In 1997, the Danish scientist Jens Chr. Skou received the Nobel Prize in Chemistry for his discovery, and over the years, research on the pump has remained a strong focus area at Aarhus University.

23 Sep 2013

PGI2 analogs, PDE5 inhibitors stimulate enhanced release of vasodilator ATP from human RBCs

Researchers at Saint Louis University School of Medicine have discovered a novel interaction between prostacyclin analogs and phosphodiesterase 5 inhibitors, two groups of drugs used in the treatment of pulmonary arterial hypertension.

21 Sep 2013

Cellectricon awards Cellaxess ACE project grant to support research in cell biology

Cellectricon, a leading provider of advanced cell-based screening technologies and services, has announced the two winners of its Cellaxess ACE project grant, supporting cutting-edge research in cell biology.

From Cellectricon 21 Sep 2013

Researchers make new breakthroughs in brain circuitry controlling fertility

In a landmark discovery, the final piece in the puzzle of understanding how the brain circuitry vital to normal fertility in humans and other mammals operates has been put together by researchers at New Zealand's University of Otago.

21 Sep 2013

Drexel University researchers create molecule that can cause AIDS virus to destroy itself

Pinning down an effective way to combat the spread of the human immunodeficiency virus, the viral precursor to AIDS, has long been challenge task for scientists and physicians, because the virus is an elusive one that mutates frequently and, as a result, quickly becomes immune to medication.

20 Sep 2013

UdeM's IRIC and Bristol-Myers Squibb identify small molecule drug candidate against novel target

Universit- de Montr-al and the Institute for Research in Immunology and Cancer - Commercialization of Research today announced that researchers from UdeM's Institute for Research in Immunology and Cancer and Bristol-Myers Squibb Company have jointly identified a small molecule drug candidate against a novel target.

20 Sep 2013

Study explains indirect burden of malaria on childhood deaths

Recurrent episodes of malaria cause chronic inflammation in blood vessels that might predispose to future infections and may increase susceptibility to cardiovascular disease, a Wellcome Trust study in Malawian children finds.

20 Sep 2013

NIH announces $45 million grant to find effective interventions for Alzheimer's

The National Institutes of Health announced on Wednesday the award of a new research grant to discover, characterize and validate complex molecular networks and candidate genes that influence susceptibility to cognitive decline and Alzheimer's disease.

19 Sep 2013

Researchers identify likely molecular pathway that causes untreatable neurodegenerative diseases

University of Adelaide researchers have identified a likely molecular pathway that causes a group of untreatable neurodegenerative diseases, including Huntington's disease and Lou Gehrig's disease.

19 Sep 2013

Molecule News and Research

Astrazeneca Licenses 3 X-Chem Drug Discovery Programs

First Direct Measurement Of Spinal Cord Myelin In MS

Abbvie, Galapagos Ink Up To $405M CF Collaboration

Astrazeneca Licenses 3 X-Chem Drug Discovery Programs

Abbvie, Galapagos Ink Up To $405M CF Collaboration

Understanding genetic, physiological basis for metabolic diseases related to circadian function

Researchers develop first imaging tool to examine myelin damage in MS

Researchers discover drug that halts growth of brain tumor cells

Lpath receives NIH SBIR grant to investigate effect of Lpathomab compound on diabetic neuropathy

Researchers report encouraging results from T1DAL study on type 1 diabetes

New study on propofol drug may help develop effective anesthetics with fewer side effects

Sodium-potassium pump is pivotal to body's function

PGI2 analogs, PDE5 inhibitors stimulate enhanced release of vasodilator ATP from human RBCs

Cellectricon awards Cellaxess ACE project grant to support research in cell biology

Researchers make new breakthroughs in brain circuitry controlling fertility

Drexel University researchers create molecule that can cause AIDS virus to destroy itself

UdeM's IRIC and Bristol-Myers Squibb identify small molecule drug candidate against novel target

Study explains indirect burden of malaria on childhood deaths

NIH announces $45 million grant to find effective interventions for Alzheimer's

Researchers identify likely molecular pathway that causes untreatable neurodegenerative diseases

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News